News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

News

New Website Launch

NEWCASTLE UPON TYNE, UK, 29 APRIL 2022. QuantuMDx Group Limited (“QuantuMDx”), is thrilled to announce the launch of a new website www.quantumdx.com/. Our new website features improved functionalities and easy access to essential information about our solution and our brand…

News

QuantuMDx wins two Bionow Awards 2021

NEWCASTLE UPON TYNE, UK, 01 APRIL 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce…

News

QuantuMDx team at North East Medical Life Science Awards

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

NEWCASTLE UPON TYNE, UK, 25 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce…

News

A box full of small medical jars with white lids

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 10 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its SARS-CoV-2 RT -PCR detection assay, has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…

Previous Next

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

New Website Launch

QuantuMDx wins two Bionow Awards 2021

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

CAPTURE-XT

TB Host Immune Response Assay (TB-HIRA)

Q-POC Platform

Respiratory Solution